Jichu yixue yu linchuang (Feb 2022)

Research progress on drug targets for anti-retinal and choroidal neovascular diseases

  • LIU Chen, FANG Si-yin, GU Cao, WU Jin-hui

DOI
https://doi.org/10.16352/j.issn.1001-6325.2022.02.011
Journal volume & issue
Vol. 42, no. 2
pp. 325 – 329

Abstract

Read online

The appearance of new blood vessels in the neovascular age-related macular degeneration (nAMD), diabetic retinopathy (DR),and other ocular diseases is one of the important reasons for blindness. Anti-vascular endothelial growth factor (VEGF) drugs are the current mainstream. However, some patients have poor efficacy and other adverse reactions. There is still a need to develop new drugs.

Keywords